You just read:

CTI BioPharma And Baxalta Complete Submission Of New Drug Application For Pacritinib For Unmet Medical Need In Myelofibrosis

News provided by

CTI BioPharma Corp.; Baxalta Incorporated

Jan 05, 2016, 01:30 ET